Cryoballoon catheter ablation or drug therapy to delay progression of atrial fibrillation: A single-center randomized trial
BackgroundDelaying atrial fibrillation (AF) progression is a key goal in cardiovascular treatment. However, numbers of previously published studies on delayed AF progression are relatively limited. The purpose of this study was to determine whether a cryoballoon catheter ablation (CA) strategy could...
Main Authors: | Jun Ding, Aijuan Cheng, Peng Li, Yingchuan Yan, Yutian Shi, Zuochen Xue, Shan Sun, Jing Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.1003305/full |
Similar Items
-
Cryoballoon Ablation Strategy in Persistent Atrial Fibrillation
by: Florian Straube, et al.
Published: (2021-11-01) -
Cryoballoon Ablation for Atrial Fibrillation
by: Jason G. Andrade, MD, et al.
Published: (2012-03-01) -
Relationship between serum osteopontin level and atrial fibrillation recurrence in patients undergoing cryoballoon catheter ablation
by: Hacı Murat Güneş, et al.
Published: (2017-01-01) -
A novel individualized strategy for cryoballoon catheter ablation in patients with paroxysmal atrial fibrillation
by: Jun Ding, et al.
Published: (2019-12-01) -
Sex Differences in the Outcomes of Cryoablation for Atrial Fibrillation
by: Alexis Hermida, et al.
Published: (2022-05-01)